Kank-A
Kank-A is a liquid pharmaceutical product marketed by Blistex used primarily to treat canker sores. It is applied directly on the sore and works by numbing the local area (with benzocaine) to prevent discomfort and forming a protective mucous barrier with a compound benzoin tincture that protects the ulcer from further irritation, allowing it to heal more rapidly.

As of 2014, Kank-A comes in two varieties, the original providing oral pain relief against canker sores, and a soft gel that provides oral pain relief of toothaches.
Q12140
pharmaceutical
Concept
Q4926914
Blistex
Concept
Q189956
canker sores
Concept
Q422745
benzocaine
Concept
Q7808030
benzoin tincture
UNK
Q3192689
Kank-A
UNK
Q3192689
Kank-A
UNK
2014-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2014
DATE
inception